Status:
UNKNOWN
The JULI Registry--Hemp and Cannabis Observational Registry
Lead Sponsor:
Juva Life
Collaborating Sponsors:
Targeted Medical Education
Conditions:
Chronic Pain
Appetite Disorders
Eligibility:
All Genders
21+ years
Brief Summary
The JuLi Registry seeks to fill some of the gaps associated with the clinical use of CBD (cannabidiol) and other cannabinoid formulations including THC and others. The overarching goal of this Registr...
Detailed Description
The JuLi Registry seeks to fill some of the gaps associated with the clinical application of CBD (cannabidiol) and other cannabinoid formulations including THC and others. It will also serve as a plat...
Eligibility Criteria
Inclusion
- 21 years of age or older
- Have requested from and/or decided with their providers to try CBD (hemp-based) or other cannabis products to relieve one or more symptoms related to a medical diagnosis
- Consent to have their health data included in a Registry and participate in PRO (patient reported outcomes) surveys and data collection via a study app.
Exclusion
- Patient pregnant
- Unwilling or unable to provide informed consent
Key Trial Info
Start Date :
August 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 15 2025
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04726254
Start Date
August 1 2021
End Date
February 15 2025
Last Update
July 19 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Precision Cancer Specialists
Los Gatos, California, United States, 95032
2
Justin Lo MD
San Jose, California, United States, 95128
3
Nashville Breast Center
Nashville, Tennessee, United States, 37203
4
Dallas Surgical Group
Dallas, Texas, United States, 75231